HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yifei Wang Selected Research

PAMAM-G4

10/2020cRGD mediated redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for efficiently intracellular antitumor drug delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yifei Wang Research Topics

Disease

77Neoplasms (Cancer)
10/2022 - 09/2004
45Infections
05/2022 - 08/2003
16Virus Diseases (Viral Diseases)
03/2022 - 01/2008
14Inflammation (Inflammations)
06/2022 - 01/2013
11Neoplasm Metastasis (Metastasis)
09/2021 - 11/2010
9COVID-19
11/2022 - 01/2020
9Hepatocellular Carcinoma (Hepatoma)
03/2022 - 01/2009
9Carcinogenesis
01/2022 - 01/2018
9Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 11/2010
6Breast Neoplasms (Breast Cancer)
07/2022 - 07/2017
5Squamous Cell Carcinoma of Head and Neck
05/2022 - 01/2018
5Wounds and Injuries (Trauma)
03/2022 - 01/2016
5Esophageal Squamous Cell Carcinoma
01/2021 - 01/2015
5Esophageal Neoplasms (Esophageal Cancer)
08/2017 - 01/2015
4Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 05/2015
4Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 10/2015
4Stroke (Strokes)
03/2022 - 01/2012
4Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2011
4Melanoma (Melanoma, Malignant)
01/2022 - 03/2021
4Body Weight (Weight, Body)
06/2021 - 01/2015
4Communicable Diseases (Infectious Diseases)
11/2020 - 08/2003
3Multiple Sclerosis
09/2022 - 02/2022
3Starvation
01/2022 - 01/2009
3Dysbiosis
01/2022 - 06/2017
3Acute Lung Injury
01/2022 - 01/2017
3Pain (Aches)
01/2022 - 08/2017
3Adenocarcinoma
06/2021 - 08/2015
3Parkinson Disease (Parkinson's Disease)
01/2021 - 04/2015
3Obesity
01/2021 - 01/2013
3Lymphatic Metastasis
10/2020 - 12/2010
3Gouty Arthritis
01/2020 - 01/2020
3Carcinoma (Carcinomatosis)
01/2018 - 06/2010
3Autistic Disorder (Autism)
01/2018 - 01/2017
2Herpes Simplex
05/2022 - 02/2004
2Lung Neoplasms (Lung Cancer)
03/2022 - 01/2022
2Rheumatoid Arthritis
02/2022 - 02/2019
2Fatigue
01/2022 - 02/2015
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 01/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2021
2Bites and Stings (Sting)
01/2022 - 01/2021
2Herpes Simplex Encephalitis (Herpes Encephalitis)
01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2011
22Antiviral Agents (Antivirals)IBA
05/2022 - 06/2010
15Pharmaceutical PreparationsIBA
02/2022 - 04/2014
14Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2004
11CytokinesIBA
01/2022 - 01/2017
11Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2021 - 09/2013
8RNA (Ribonucleic Acid)IBA
10/2022 - 07/2011
8MicroRNAs (MicroRNA)IBA
09/2022 - 06/2014
7SNX 2112IBA
01/2019 - 09/2013
6Messenger RNA (mRNA)IBA
01/2022 - 01/2018
6LipidsIBA
01/2022 - 01/2015
6Cisplatin (Platino)FDA LinkGeneric
12/2021 - 05/2015
6LigandsIBA
03/2021 - 07/2014
6Long Noncoding RNAIBA
01/2021 - 09/2017
5Biological ProductsIBA
01/2022 - 01/2009
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 03/2016
5EnzymesIBA
01/2021 - 01/2008
5Lewis Y antigenIBA
06/2015 - 11/2010
4Acyclovir (Aciclovir)FDA LinkGeneric
05/2022 - 03/2015
4Interferon Type IIBA
01/2022 - 01/2021
4Immunoconjugates (Immunoconjugate)IBA
01/2022 - 01/2021
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2014
4Uric Acid (Urate)IBA
01/2021 - 05/2016
4DNA (Deoxyribonucleic Acid)IBA
10/2019 - 01/2009
4Actin Depolymerizing Factors (Cofilins)IBA
09/2016 - 08/2012
4Actins (F Actin)IBA
10/2014 - 08/2012
3AntibodiesIBA
11/2022 - 04/2007
3Estrogen ReceptorsIBA
01/2022 - 01/2017
3AntigensIBA
01/2022 - 04/2007
3InflammasomesIBA
01/2022 - 10/2018
3GemcitabineFDA Link
06/2021 - 06/2018
3cepharanthineIBA
01/2021 - 02/2004
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 10/2015
3AntioxidantsIBA
01/2020 - 02/2015
3Polysaccharides (Glycans)IBA
01/2020 - 02/2015
3Therapeutic UsesIBA
01/2020 - 05/2018
3Molecular Chaperones (Chaperone, Molecular)IBA
01/2019 - 09/2013
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 06/2017
3gypenosideIBA
08/2017 - 03/2016
3IntegrinsIBA
06/2015 - 12/2010
3OligosaccharidesIBA
06/2015 - 11/2010
2CreatinineIBA
11/2022 - 05/2022
2N-methyladenosineIBA
10/2022 - 01/2021
2MethyltransferasesIBA
10/2022 - 01/2021
26-methyladenineIBA
10/2022 - 01/2021
2p38 Mitogen-Activated Protein KinasesIBA
01/2022 - 10/2014
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2022 - 01/2021
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2022 - 01/2017
2FructoseIBA
01/2022 - 01/2015
2OvalbuminIBA
01/2022 - 01/2020
2TamoxifenFDA LinkGeneric
01/2022 - 04/2014
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 12/2019
2ResveratrolIBA
01/2022 - 01/2018
2Mechanistic Target of Rapamycin Complex 2IBA
01/2022 - 01/2018

Therapy/Procedure

36Therapeutics
05/2022 - 03/2014
13Drug Therapy (Chemotherapy)
01/2022 - 06/2011
6Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2020 - 06/2015
4Immunotherapy
01/2021 - 01/2019
2Chemoradiotherapy
05/2022 - 01/2021